PSI CRO - Clinical Operations
in Oncology Trials Europe 2022

Meet us in Zurich November 22 and 23
Mövenpick Hotel Zürich-Regensdorf, Zurich, Switzerland

With broad access to experienced global sites, our machine-learning-powered study modeling tool, and extensive therapeutic expertise, PSI remains a key player in providing successful patient enrollment and full-service management of oncology trials. 90% of our Project Managers and 79% of our CRAs have oncology clinical trials experience. Submit the form on this page to RSVP or schedule a personal meeting to learn how you can tap into our long-term site relationships with more than 2,500+ oncology sites around the world.
Helen Nelson

Senior Director, Business Development

Sylvia Demandewicz

Senior Director, Business Development

Focused and specialized global CRO for oncology clinical trials
PSI has diverse experience in various classes of small molecules and biologics across a broad spectrum of cancers. Our experience with immunotherapies, biosimilars, radiopharmaceuticals, and more, allows us to have a deep understanding of how to plan and execute complex clinical trials on time, saving our customers millions of development dollars.
Learn more about PSI’s oncology experience with these resources below
Running oncology studies globally. We plan and execute seamless clinical trials with novel study designs.
NSCLC Clinical Trials: History, Trends, and Opportunities
Cutting Startup Timelines in Half on a Global HemOnc Study

The PSI Advantage

PSI CRO has been named a 2022 CRO Leadership Award Champion in the categories of Compatibility, Quality, and Reliability across two respondent groups (Overall and Small Pharma). This is also the fourth year in a row in which PSI CRO received CRO Leadership Awards in all five categories, also including Expertise and Capabilities. The CRO Leadership Awards are presented by Life Sciences Leader and Clinical Leader based on research conducted by ISR reports. The awards recognize CROs that are voted by sponsors to meet or exceed expectations.